CA2033433C - Detection des atteintes du systeme nerveux autonome associees a des neuropathies et methode d'analyse - Google Patents

Detection des atteintes du systeme nerveux autonome associees a des neuropathies et methode d'analyse

Info

Publication number: CA2033433C
Authority: CA; Canada
Prior art keywords: patient; test result; nervous system; heart beat; test
Prior art date: 1990-12-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 2033433

Other languages

English (en)

Other versions

CA2033433A1 (fr

Inventor

Teri J. Kraf

William R. Frisbie

Allan Rosner

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Qmed Inc

Original Assignee

Qmed Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-14

Filing date

1990-12-28

Publication date

1996-07-16

1990-12-14 Priority claimed from US07/626,710 external-priority patent/US5299119A/en

1990-12-28 Application filed by Qmed Inc filed Critical Qmed Inc

1992-06-15 Publication of CA2033433A1 publication Critical patent/CA2033433A1/fr

1996-07-16 Application granted granted Critical

1996-07-16 Publication of CA2033433C publication Critical patent/CA2033433C/fr

2010-12-28 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000004458 analytical method Methods 0.000 title claims description 19
206010061666 Autonomic neuropathy Diseases 0.000 title description 16
238000001514 detection method Methods 0.000 title description 16
238000012360 testing method Methods 0.000 claims abstract description 182
210000002216 heart Anatomy 0.000 claims abstract description 113
230000029058 respiratory gaseous exchange Effects 0.000 claims abstract description 62
230000002159 abnormal effect Effects 0.000 claims abstract description 32
210000000653 nervous system Anatomy 0.000 claims abstract description 16
238000012544 monitoring process Methods 0.000 claims abstract description 8
238000000034 method Methods 0.000 claims description 41
210000003403 autonomic nervous system Anatomy 0.000 claims description 25
206010012601 diabetes mellitus Diseases 0.000 claims description 22
230000006870 function Effects 0.000 claims description 12
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 10
230000003906 autonomic nervous system functioning Effects 0.000 claims description 8
201000010099 disease Diseases 0.000 claims description 8
230000003287 optical effect Effects 0.000 claims description 8
239000013598 vector Substances 0.000 claims description 6
206010042434 Sudden death Diseases 0.000 claims description 5
208000007848 Alcoholism Diseases 0.000 claims description 3
208000001089 Multiple system atrophy Diseases 0.000 claims description 3
208000009106 Shy-Drager Syndrome Diseases 0.000 claims description 3
208000031886 HIV Infections Diseases 0.000 claims description 2
208000037357 HIV infectious disease Diseases 0.000 claims description 2
208000027089 Parkinsonian disease Diseases 0.000 claims description 2
206010034010 Parkinsonism Diseases 0.000 claims description 2
208000029078 coronary artery disease Diseases 0.000 claims description 2
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims description 2
201000001881 impotence Diseases 0.000 claims description 2
201000002859 sleep apnea Diseases 0.000 claims description 2
230000000007 visual effect Effects 0.000 claims description 2
238000010223 real-time analysis Methods 0.000 claims 2
206010067722 Toxic neuropathy Diseases 0.000 claims 1
231100000126 Toxic neuropathy Toxicity 0.000 claims 1
230000004217 heart function Effects 0.000 claims 1
201000006938 muscular dystrophy Diseases 0.000 claims 1
230000002802 cardiorespiratory effect Effects 0.000 abstract description 3
238000000718 qrs complex Methods 0.000 abstract 1
208000033808 peripheral neuropathy Diseases 0.000 description 16
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
201000001119 neuropathy Diseases 0.000 description 8
230000007823 neuropathy Effects 0.000 description 8
230000002567 autonomic effect Effects 0.000 description 7
230000000241 respiratory effect Effects 0.000 description 7
241001163743 Perlodes Species 0.000 description 6
210000005036 nerve Anatomy 0.000 description 6
230000004044 response Effects 0.000 description 6
230000008859 change Effects 0.000 description 5
230000003434 inspiratory effect Effects 0.000 description 5
102000004877 Insulin Human genes 0.000 description 4
108090001061 Insulin Proteins 0.000 description 4
238000004364 calculation method Methods 0.000 description 4
229940125396 insulin Drugs 0.000 description 4
230000001734 parasympathetic effect Effects 0.000 description 4
230000000747 cardiac effect Effects 0.000 description 3
230000001447 compensatory effect Effects 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000011156 evaluation Methods 0.000 description 3
208000017169 kidney disease Diseases 0.000 description 3
238000005259 measurement Methods 0.000 description 3
238000012806 monitoring device Methods 0.000 description 3
208000010125 myocardial infarction Diseases 0.000 description 3
210000004165 myocardium Anatomy 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
230000002093 peripheral effect Effects 0.000 description 3
238000003825 pressing Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
230000011514 reflex Effects 0.000 description 3
230000001105 regulatory effect Effects 0.000 description 3
230000002889 sympathetic effect Effects 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
206010003840 Autonomic nervous system imbalance Diseases 0.000 description 2
208000032131 Diabetic Neuropathies Diseases 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
241000725303 Human immunodeficiency virus Species 0.000 description 2
206010000891 acute myocardial infarction Diseases 0.000 description 2
201000007930 alcohol dependence Diseases 0.000 description 2
230000037424 autonomic function Effects 0.000 description 2
231100000877 autonomic nervous system dysfunction Toxicity 0.000 description 2
230000008901 benefit Effects 0.000 description 2
210000004027 cell Anatomy 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000003745 diagnosis Methods 0.000 description 2
208000035475 disorder Diseases 0.000 description 2
230000002526 effect on cardiovascular system Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000008103 glucose Substances 0.000 description 2
230000002107 myocardial effect Effects 0.000 description 2
230000007830 nerve conduction Effects 0.000 description 2
230000000926 neurological effect Effects 0.000 description 2
230000036407 pain Effects 0.000 description 2
210000000578 peripheral nerve Anatomy 0.000 description 2
208000027232 peripheral nervous system disease Diseases 0.000 description 2
230000001144 postural effect Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
238000012552 review Methods 0.000 description 2
230000035807 sensation Effects 0.000 description 2
231100000331 toxic Toxicity 0.000 description 2
238000012546 transfer Methods 0.000 description 2
238000011282 treatment Methods 0.000 description 2
208000001072 type 2 diabetes mellitus Diseases 0.000 description 2
DYUUGILMVYJEHY-UHFFFAOYSA-N 1-$l^{1}-oxidanyl-4,4,5,5-tetramethyl-3-oxido-2-phenylimidazol-3-ium Chemical compound CC1(C)C(C)(C)N([O])C(C=2C=CC=CC=2)=[N+]1[O-] DYUUGILMVYJEHY-UHFFFAOYSA-N 0.000 description 1
208000030507 AIDS Diseases 0.000 description 1
206010000060 Abdominal distension Diseases 0.000 description 1
235000003625 Acrocomia mexicana Nutrition 0.000 description 1
244000202285 Acrocomia mexicana Species 0.000 description 1
200000000007 Arterial disease Diseases 0.000 description 1
206010003591 Ataxia Diseases 0.000 description 1
206010056339 Autonomic failure syndrome Diseases 0.000 description 1
235000016068 Berberis vulgaris Nutrition 0.000 description 1
241000335053 Beta vulgaris Species 0.000 description 1
206010069632 Bladder dysfunction Diseases 0.000 description 1
206010010947 Coordination abnormal Diseases 0.000 description 1
208000002249 Diabetes Complications Diseases 0.000 description 1
206010012645 Diabetic autonomic neuropathy Diseases 0.000 description 1
206010012655 Diabetic complications Diseases 0.000 description 1
208000002705 Glucose Intolerance Diseases 0.000 description 1
101150087426 Gnal gene Proteins 0.000 description 1
PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
101150064776 Msln gene Proteins 0.000 description 1
206010031127 Orthostatic hypotension Diseases 0.000 description 1
208000030374 Pupillary disease Diseases 0.000 description 1
208000017442 Retinal disease Diseases 0.000 description 1
208000034189 Sclerosis Diseases 0.000 description 1
206010040030 Sensory loss Diseases 0.000 description 1
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000032683 aging Effects 0.000 description 1
230000001476 alcoholic effect Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
238000002266 amputation Methods 0.000 description 1
210000003423 ankle Anatomy 0.000 description 1
208000028922 artery disease Diseases 0.000 description 1
210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
235000013405 beer Nutrition 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
239000006227 byproduct Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
208000018631 connective tissue disease Diseases 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
210000004351 coronary vessel Anatomy 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
230000000254 damaging effect Effects 0.000 description 1
238000013500 data storage Methods 0.000 description 1
238000013461 design Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
238000010586 diagram Methods 0.000 description 1
230000037213 diet Effects 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
230000004064 dysfunction Effects 0.000 description 1
238000013399 early diagnosis Methods 0.000 description 1
238000002567 electromyography Methods 0.000 description 1
239000003925 fat Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
210000002683 foot Anatomy 0.000 description 1
230000002496 gastric effect Effects 0.000 description 1
210000004907 gland Anatomy 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
208000016290 incoordination Diseases 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000001788 irregular Effects 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
210000003127 knee Anatomy 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
210000002414 leg Anatomy 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
238000007726 management method Methods 0.000 description 1
QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
229910052753 mercury Inorganic materials 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
201000006417 multiple sclerosis Diseases 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000004126 nerve fiber Anatomy 0.000 description 1
239000003538 oral antidiabetic agent Substances 0.000 description 1
229940127209 oral hypoglycaemic agent Drugs 0.000 description 1
230000037324 pain perception Effects 0.000 description 1
230000007170 pathology Effects 0.000 description 1
230000007310 pathophysiology Effects 0.000 description 1
230000008447 perception Effects 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
235000009991 pite Nutrition 0.000 description 1
244000293655 pite Species 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
230000002028 premature Effects 0.000 description 1
238000007639 printing Methods 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
238000011160 research Methods 0.000 description 1
230000036299 sexual function Effects 0.000 description 1
210000002460 smooth muscle Anatomy 0.000 description 1
230000000392 somatic effect Effects 0.000 description 1
238000013517 stratification Methods 0.000 description 1
239000000126 substance Substances 0.000 description 1
230000035900 sweating Effects 0.000 description 1
230000001360 synchronised effect Effects 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000003371 toe Anatomy 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
238000011277 treatment modality Methods 0.000 description 1
210000001186 vagus nerve Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1

Landscapes

Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

CA 2033433 1990-12-14 1990-12-28 Detection des atteintes du systeme nerveux autonome associees a des neuropathies et methode d'analyse Expired - Fee Related CA2033433C (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US07/626,710 US5299119A (en)	1989-07-06	1990-12-14	Autonomic neuropathy detection and method of analysis
US07/626,710		1990-12-14

Publications (2)

Publication Number	Publication Date
CA2033433A1 CA2033433A1 (fr)	1992-06-15
CA2033433C true CA2033433C (fr)	1996-07-16

Family

ID=24511506

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2033433 Expired - Fee Related CA2033433C (fr)	1990-12-14	1990-12-28	Detection des atteintes du systeme nerveux autonome associees a des neuropathies et methode d'analyse

Country Status (1)

Country	Link
CA (1)	CA2033433C (fr)

1990
- 1990-12-28 CA CA 2033433 patent/CA2033433C/fr not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CA2033433A1 (fr)	1992-06-15

Legal Events

Date	Code	Title	Description
1994-06-15	EEER	Examination request
2009-12-29	MKLA	Lapsed

Publication	Publication Date	Title
US5299119A (en)	1994-03-29	Autonomic neuropathy detection and method of analysis
US4982738A (en)	1991-01-08	Diagnostic apnea monitor system
Mulder	1992	Measurement and analysis methods of heart rate and respiration for use in applied environments
EP0479947B1 (fr)	1995-11-29	Procede et dispositif de controle cardiaque non invasif
Stuyck et al.	2022	Validity of the Empatica E4 wristband to estimate resting-state heart rate variability in a lab-based context
US9265430B2 (en)	2016-02-23	Method, system and software product for the measurement of heart rate variability
Ewing et al.	1991	Twenty four hour heart rate variability: effects of posture, sleep, and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients.
Obrist et al.	1987	Cardiovascular responses to stress: I. Measures of myocardial response and relationship to high resting systolic pressure and parental hypertension
US4930518A (en)	1990-06-05	Sinus arrhythmia monitor
US8795189B2 (en)	2014-08-05	System and method for determining pulmonary performance from transthoracic impedance measures
US6936011B2 (en)	2005-08-30	Analysis of sleep apnea
US4854327A (en)	1989-08-08	Non-invasive and continuous cardiac performance monitoring device
Hornung et al.	1989	Ambulatory blood pressure and heart rate in diabetic patients: an assessment of autonomic function
US20050187480A1 (en)	2005-08-25	Blood pressure measurement apparatus and method
US20030055343A1 (en)	2003-03-20	Monitoring a condition of a patient under anaesthesia or sedation
HU215658B (hu)	1999-02-01	Eljárás és berendezés altatási mélység mértékének meghatározására
JPH11504840A (ja)	1999-05-11	睡眠障害の定量的分析装置及び方法
WO1996032055A1 (fr)	1996-10-17	Surveillance de reveils apneiques et hypopneiques
EP3533389A1 (fr)	2019-09-04	Procédés et systèmes permettant de mesurer un indicateur de contrainte et pour déterminer un niveau de stress chez un individu
EP2085025B1 (fr)	2016-01-06	Appareil de mesure d'activité nerveuse automatique et procédé de mesure d'activité nerveuse autonomique
Wang et al.	1993	Respiratory sinus arrhythmia: a new, objective sedation score
GB2469547A (en)	2010-10-20	Measurement of heart rate variability
US20110184298A1 (en)	2011-07-28	Portable cardio waveform acquisiton and heart rate variability (hrv) analysis
JP3596117B2 (ja)	2004-12-02	体調判定支援装置
CA2033433C (fr)	1996-07-16	Detection des atteintes du systeme nerveux autonome associees a des neuropathies et methode d'analyse